GP-Act III Acquisition EBIT

GP-Act III Acquisition (GPAT) currently reports a EBIT of $-2.2M as of June 2026. That compares with $-670K in the prior-year period — down 235.3% year over year. That is above the sector sector average of $-6.4M. Use the charts on this page to explore GP-Act III Acquisition's EBIT history and peer comparisons.

GP-Act III Acquisition's EBIT decreased from $-670K to $-2.2M — a 235.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

GP-Act III Acquisition's EBIT of $-2.2M is higher than the its sector sector average of $-6.4M. That is roughly 65.0% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

GP-Act III Acquisition reported $-2.2M in EBIT as of June 2026. That compares with $-670K in the prior-year period — down 235.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-2.2M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $-6.4M. From there, open related valuation or income-statement pages for GP-Act III Acquisition, and consider following GPAT for alerts when major investors trade the stock.